Jong Seok Lee

机构：Seoul National University Bundang Hospital · ORCID：0000-0002-7945-2530

发表论文 1871 篇 · 总被引 15050 次 · h-index 50

代表论文

• Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer (2024 · New England Journal of Medicine · 被引 425)
• Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study (2025 · Journal of Clinical Oncology · 被引 121)
• Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study (2024 · Lung Cancer · 被引 81)
• CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial (2024 · Investigational New Drugs · 被引 79)
• A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC (2025 · Journal of Thoracic Oncology · 被引 57)
• Amivantamab plus lazertinib in atypical EGFR-mutated advanced non-small cell lung cancer (NSCLC): Results from CHRYSALIS-2. (2024 · Journal of Clinical Oncology · 被引 20)